Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.5M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
6.1M
-
Shares change
-
-1.24M
-
Total reported value, excl. options
-
$48.3M
-
Value change
-
-$15.6M
-
Put/Call ratio
-
3.45
-
Number of buys
-
36
-
Number of sells
-
-44
-
Price
-
$7.92
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q2 2024
95 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q2 2024.
AVITA Medical, Inc. - Common Stock (RCEL) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.1M shares
of 26.5M outstanding shares and own 23.04% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.78M shares), VANGUARD GROUP INC (1.4M shares), GEODE CAPITAL MANAGEMENT, LLC (586K shares), STATE STREET CORP (508K shares), Soleus Capital Management, L.P. (267K shares), NORTHERN TRUST CORP (213K shares), MORGAN STANLEY (109K shares), GOLDMAN SACHS GROUP INC (93.5K shares), D. E. Shaw & Co., Inc. (84.8K shares), and WELLINGTON MANAGEMENT GROUP LLP (73.2K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.